跳至主要内容
临床试验/DRKS00007183
DRKS00007183已完成不适用

MARTA- Non-interventional observational study to document the efficacy and tolerability of taxanes (Docetaxel, Paclitaxel) in treatment against operable, nodal-positive and locally advanced metastatic mamma carzinoma - MARTA

AxioNovo GmbH0 个研究点目标入组 558 人开始时间: 2014年11月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AxioNovo GmbH
入组人数
558

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
Female

入选标准

  • Signed and dated consent is available
  • - The treatment decision was made independently of a possible inclusion in the study
  • - Patient is not at the same time a clinical trial participant
  • - Patient is at least 18 years old.

排除标准

  • - Contraindications to the use of Axiplatin according to the SmPC.
  • - Current therapy was started more than 12 weeks ago.
  • - The patient is concurrently participating in a clinical trial.
  • - Pregnancy is present or the patient is breastfeeding.

研究者

发起方
AxioNovo GmbH

相似试验